LivingGLP1
Study S001304

A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass

Registration

Registration
NCT04615910
Acronym
Ver-A-image
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE2
Masking
SINGLE
Status
UNKNOWN
Enrollment
30
Start
2021-07-01
Primary completion
2025-04-01
Lead sponsor
Radboud University Medical Center
Conditions
Diabetes Mellitus
Interventions
RADIATION:68Ga-NODAGA-exendin-4 PET/CT
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Pancreatic 68Ga-exendin uptake [Change from time of inclusion to 12 months into treatment]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.